Astrazeneca (AZN) Short term Debt (2009 - 2026)
Astrazeneca (AZN) posted quarterly Short term Debt of $5.8 billion for Q2 2026, down 10.54% year-over-year from $6.5 billion in Q2 2025, and up 123.75% quarter-over-quarter from -$24.5 billion in Q1 2026.
Astrazeneca (AZN) Short term Debt (2009 - 2026) Analysis & Trends
Astrazeneca's Short term Debt history runs 18 years deep, the most recent figure standing at $5.8 billion for Q2 2026.
- In Q2 2026, Short term Debt fell 10.54% year-over-year to $5.8 billion; the TTM figure through Jun 2026 stood at $5.8 billion (down 10.54% YoY), while the FY2025 annual figure was $3.1 billion, up 32.82% from the prior year.
- Short term Debt for Q2 2026 stood at $5.8 billion, up from -$24.5 billion in the prior quarter.
- The five-year high for Short term Debt was $6.5 billion in Q2 2025, with the low at -$28.9 billion in Q3 2024.
- The 5-year median for Short term Debt is -$24.4 billion (2023), against an average of -$15.7 billion.
- Peak annual rise in Short term Debt reached 220.12% in 2022, while the deepest fall reached 104.14% in 2022.
- Astrazeneca's Short term Debt stood at $5.3 billion in 2022, then fell by 3.48% to $5.1 billion in 2023, then tumbled by 54.44% to $2.3 billion in 2024, then soared by 32.82% to $3.1 billion in 2025, then soared by 87.11% to $5.8 billion in 2026.
- Business Quant data shows AZN's Short term Debt at $5.8 billion in Q2 2026, -$24.5 billion in Q1 2026, and $3.1 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.29 Bn | 631.53 Bn | 17.26 Bn |
| 2 | AbbVie | 469.70 Bn | 463.14 Bn | 12.70 Bn |
| 3 | Merck | 374.92 Bn | 367.78 Bn | 12.21 Bn |
| 4 | Novartis Ag | 302.99 Bn | 295.30 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.60 Bn | 252.70 Bn | 12.86 Bn |
| 6 | Amgen | 236.63 Bn | 222.64 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 182.46 Bn | 179.28 Bn | 6.22 Bn |
| 8 | Pfizer | 159.59 Bn | 147.89 Bn | 10.94 Bn |
| 9 | Gsk | 106.12 Bn | 101.95 Bn | 8.24 Bn |
| 10 | Sanofi | 55.21 Bn | 47.83 Bn | 10.79 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.81 Bn |
| Mar 31, 2026 | -24.45 Bn |
| Dec 31, 2025 | 3.10 Bn |
| Sep 30, 2025 | -24.70 Bn |
| Jun 30, 2025 | 6.49 Bn |
| Mar 31, 2025 | -26.69 Bn |
| Dec 31, 2024 | 2.34 Bn |
| Sep 30, 2024 | -28.89 Bn |
| Jun 30, 2024 | -27.23 Bn |
| Mar 31, 2024 | -27.26 Bn |
| Dec 31, 2023 | 5.13 Bn |
| Sep 30, 2023 | -22.23 Bn |
| Jun 30, 2023 | -24.33 Bn |
| Mar 31, 2023 | -26.92 Bn |
| Dec 31, 2022 | 5.31 Bn |
| Sep 30, 2022 | -23.01 Bn |
| Jun 30, 2022 | -26.46 Bn |
| Mar 31, 2022 | -28.08 Bn |
| Dec 31, 2021 | 1.66 Bn |
| Sep 30, 2021 | -28.21 Bn |